The largest database of trusted experimental protocols

Flp in 293

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Flp-In-293 system is a tool for the creation of stable mammalian cell lines. It facilitates the integration of a gene of interest into a specific chromosomal location in human embryonic kidney (HEK) 293 cells. The system provides a consistent and reliable method for generating stable cell lines expressing the desired protein.

Automatically generated - may contain errors

17 protocols using flp in 293

1

Establishing stable cell lines expressing PRPF4

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco's modified Eagle's medium (DMEM) and DMEM-F12 containing 10% heat-inactivated fetal calf serum (FCS) (Thermo Fisher) were used to culture human HEK293T (ATCC), HeLa cells (ATCC), Flp-In-293 (Thermo Fisher), and murine IMCD3 (ATCC) cells, respectively. Plasmids were delivered to the cells by using Plus Reagent and Lipofectamine LTX (Invitrogen) following the manufacturer's protocol. HEK293T cells stably expressing FLAG/HA-tagged human PRPF4 was generated using the pcDNA5/FRT-PRPF4 plasmid and Flp-In-293 cells according to the manufacturer's protocol (Thermo Fisher). Briefly, Flp-In-293 cells were transfected with a 9:1 ratio of pOG44:pcDNA5/FRT-PRPF4 plasmids using Lipofectamine 2000 (Invitrogen) and 48 h post-transfection, cells were selected in medium containing hygromycin. Stable clones resistant to hygromycin were expanded and tested for stable expression of FLAG-PRPF4 by Western blotting.
+ Open protocol
+ Expand
2

RMCE-in Cell Line Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
RMCE-in HEK293 or HeLa and Flp-in-293 (Life Technologies #R750-07) were seeded at 60% confluence in a 12-well plate and all transfections were made in triplicates. Cells were transfected with 250 ng donor and PGK-FlpO plasmid (5067 bp) or 250 ng empty pUC 19 control plasmid using X-tremeGENE 9 in HEK293 or XtremeGENE HP (Roche) in HeLa cells. All cells were transferred using 0.05% Trypsin-EDTA (Gibco) to 60 cm2 petri dishes the following day. Day three, cells were subject to HygR selection (100 μg/ml for HEK293 cells and 250 μg /ml for HeLa cells) and continuously HygR renewed every 3-4th day until harvested. Six million murine RMCE-in ES cells were electroporated using 10 ug donor and 10 ug FlpO plasmid (5067 bp) or 10 ug empty pUC 19 control plasmid. ES cells were seeded on mitotically inactivated murine fibroblasts and selected for 3 days with HygR (125 μg/ml).
+ Open protocol
+ Expand
3

HEK 293 Cells siRNA Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK 293 cells (Flp-In-293, from Life Technologies) were grown in Dulbecco's modified Eagle's medium (DMEM; from Sigma) supplemented with 2 mM L-glutamine (Gibco) and 10% heat-inactivated fetal calf serum (Gibco). Transfections of siRNA were carried out using Lipofectamine RNAiMAX (Life Technologies) following the manufacturer's protocol. The following siRNAs were used: negative-control from Microsynth (sense strand AGGUAGUGUAUCGCCUUGTT) and si-HNRNPC1/2 (sc-35577 from Santa Cruz Biotechnologies), both applied at 20 nM in 2.5 mL DMEM on six-well plates.
+ Open protocol
+ Expand
4

Generating Ouabain-Resistant ATP1A3 Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the Flp-In system in 293 cells, a DNA construct containing 3.5 kb of ATP1A3 full-length cDNA (GenBank accession NM_152296.4) was purchased from OriGene. 3042 bp of ATP1A3 ORF fragment was PCR-amplified using primers 5′-aaaAAGCTTggccacc-ATGGGGGACAAGAAAGATG (forward) and 5′-aaaGGATCCTCAGTAGTAGGTTTCCTTC (reverse) and subcloned in pcDNA5/FRT/TO vector using HindIII and BamHI restriction sites to produce pcDNA5/FRT/TO/ATP1A3-OR (ouabain resistant) for Tet-inducible expression in Flp-in 293 cell lines (ThermoFisher Scientific). Site-directed mutagenesis by PCR was performed to generate mutations including D366H, R463C, S729Y, D742Y, D743H, R756C, R756H, R756L, E815K, E818K, D923N, and L924P using pcDNA5/FRT/TO/ATP1A3-OR. The subcloning and site-directed mutagenesis were performed by Mutagenex (now Molecular Biology Core, The Ohio State University, Department of Surgery). All constructs were confirmed by Sanger sequencing for whole ORF sequences. For COS-1 cells, plasmids were mutagenized by PCR using the quick-change mutagenesis kit (11 (link), 47 ).
+ Open protocol
+ Expand
5

HEK293 and Flp-In-293 Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293 (human [Homo sapiens] embryonic kidney) cells were obtained from ATCC [https://www.atcc.org/] and cultured in Dulbecco´s Modified Eagle Medium (DMEM, low glucose, GlutaMaxTM Supplement, pyruvate) supplemented with 10% fetal bovine serum, 100 I.U. ml−1 penicillin, 100 µg ml−1 streptomycin, and 1.0 mg ml−1 G418. Flp-In™-293 (human [Homo sapiens] embryonic kidney) cells were obtained from Thermo Fisher Scientific and stable cell lines were generated using the Flp-In™ system from Invitrogen (Thermo Fisher Scientific, USA). Flp-In™-293 cells were cultured in DMEM (high glucose, GlutaMaxTM Supplement, pyruvate) supplemented with 10% fetal bovine serum, 100 I.U. ml−1 penicillin, 100 µg ml−1 streptomycin, and 100 µg ml−1 hygromycin B. All cell lines were incubated at 37 °C with 10% CO2.
+ Open protocol
+ Expand
6

DART System with TRDMT1 Knockout U2OS Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
U2OS TRE40 (link), TRDMT1 KO U2OS TRE22 (link), Flp-in 293 (Thermo, Cat#R75007), HS578T and MDA-MB-231 cells were cultured in Dulbecco’s modified Eagle medium (DMEM, Cat#12–604 F, Lonza; Basel, Switzerland) with 10% (vol/vol) FBS at 37 °C with 5% CO2. The U2OS-TRE cells used for the DART system have been described in previous articles40 (link). The HS578T and MDA-MB-231 cells are gifts from Dr. Leif W. Ellisen. For plasmid and siRNA transfection, Lipofectamine 2000 and Lipofectamine RNAiMax (Invitrogen; Carlsbad, CA, USA) were used following the manufacturer’s standard protocol, respectively. The siRNA for TRDMT1 was purchased from Invitrogen (siRNA ID: s4219, Cat#: 4392420). Other siRNAs include siBRCA1 (L-003461-00, Dharmacon), and siBRCA2 (GS675, Qiagen).
+ Open protocol
+ Expand
7

Mesenchymal Stem Cell Cultivation and Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary mouse C57BL/6J BM-derived MSCs were purchased from Cyagen Biosciences. 293FT, Flp-In-293, and Flp-In-Chinese hamster ovary cells were purchased from Thermo Fisher Scientific. The C3H10T1/2 cell line was purchased from the American Type Culture Collection. All of the cells were cultured in DMEM (Nacalai Tesque, Japan) supplemented with 10% fetal bovine serum. Lipofectamine 2000 (Thermo Fisher Scientific) was used for gene transfection into 293FT cells. Elastically supported surface dishes that have polydimethylsiloxane layers adjusted to a stiffness of 1.5 or 28 kPa were purchased from ibidi (µ-Dish, 35 mm, high elastically supported surface). Before seeding the cells, the surfaces of the dishes were coated with type I collagen (Col1a1; Millipore). For experiments under hypoxic conditions, cells were cultured in a humidified CO 2 /multigas incubator (APM-30D, ASTEC, Japan) with 1% O 2 , 5% CO 2, and 94% N 2 at 37°C. We used 20 and 0.25 ng/mL TGF-β to stimulate C3H10T1/2 and Flp-In Chinese hamster ovary cells, respectively.
+ Open protocol
+ Expand
8

Generating stable Flp-In 293 cell lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flp-In 293 cells (Invitrogen) were cultured in Dulbecco's modified Eagle Medium (DMEM) (Nacalai Tesque, Kyoto, Japan) containing 10% fetal bovine serum (FBS) (Biowest, Nuaillé, France), 100 units/ml penicillin and 100 μg/ml streptomycin (Nacalai Tesque) and maintained in a 5% CO2 incubator at 37°C. Flp-In 293 cells were co-transfected with pcDNA5/FRT-FLAG-NLS-DMD-Exon57_58_59(short-Intron57)-DsRed-EGFP and pOG44 (the flp recombinase expression plasmid) (Invitrogen). Stable cell lines were selected by 50 μg/ml hygromycin B (Invitrogen).
+ Open protocol
+ Expand
9

Bacterial Hosts and HEK Cell Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacterial hosts used were E. coli K12 strains: TAP114 (lacZ) deltaM15 (46 (link)) and S17–1 lambda pir (47 (link)). Escherichia coli cells were grown and plated on Luria-Bertani rich medium with the appropriate antibiotics. Plasmid transformations were performed by electroporation (48 ).
Human embryonic kidney cells HEK293 (ATCC® CRL1573™), HEK293T (ATCC® CRL-3216™), and Flp-In™-293 (Invitrogen) were cultured in Dulbecco's modified Eagle's medium (DMEM). For transient transfections HEK293T cells (∼6 × 105) were plated in a six-well plate and 24 h later treated with 3 μg of the proper plasmid DNA using PureFection Transfection Reagent (System Biosciences, Mountain View, CA, USA). For the human native ‘attB’ sites chromosomal assay transfection, Flp-In™-293 cells (∼6 × 105) were plated in a six-well plate and 24 h later treated with 5.5 μg of the proper plasmid DNA using Mirus Transfection Reagent (Mirus, WI, USA). For the CTNS and DMD chromosomal assay transfection, HEK293 cells (∼6 × 105) were plated in a six-well plate and 24 h later treated with 3 μg of the proper plasmid DNA using PureFection Transfection Reagent.
+ Open protocol
+ Expand
10

HEK293T Cell Culture and Genetic Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T (obtained from ATCC) and Flp-In-293
(Invitrogen) were cultured in MEM (Gibco
51090036
) supplemented with 10% v/v fetal bovine serum
(Sigma), penicillin/streptomycin (Gibco),
sodium pyruvate (Gibco), and non-essential amino acids
(Gibco) at 37°C in a humidified atmosphere of 5%
CO2. Medium was changed every 2–3 d. HEK293T cells
expressing shHuRs/shControls were generated as previously described.[21 (link)]
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!